Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares Repurchased
Ratios

Pharma-Bio Serv (PBSV) Shares Outstanding (2016 - 2026)

Pharma-Bio Serv filings provide 17 years of Shares Outstanding readings, the most recent being $23.5 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding changed 0.0% to $23.5 million in Q1 2026 year-over-year; TTM through Jan 2026 was $23.5 million, a 0.0% change, with the full-year FY2025 number at $23.5 million, changed 0.0% from a year prior.
  • Shares Outstanding hit $23.5 million in Q1 2026 for Pharma-Bio Serv, roughly flat from $23.5 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $23.5 million in Q1 2024 to a low of $23.5 million in Q1 2022.
  • Median Shares Outstanding over the past 5 years was $23.5 million (2024), compared with a mean of $23.5 million.
  • Biggest five-year swings in Shares Outstanding: rose 0.24% in 2023 and later changed 0.0% in 2025.
  • Pharma-Bio Serv's Shares Outstanding stood at $23.5 million in 2022, then increased by 0.24% to $23.5 million in 2023, then rose by 0.03% to $23.5 million in 2024, then changed by 0.0% to $23.5 million in 2025, then changed by 0.0% to $23.5 million in 2026.
  • The last three reported values for Shares Outstanding were $23.5 million (Q1 2026), $23.5 million (Q4 2025), and $23.5 million (Q3 2025) per Business Quant data.